This article summarized the latest R&D progress of ajmaline, the Mechanism of Action for ajmaline, and the drug target R&D trends for ajmaline.

To undertake a detailed exploration of sequence modifications and comprehend the associated specific patent information, we propose utilizing the Patsnap Bio sequence database. Boasting an extensive archive of patent literature and affiliated sequence data, this bio-database forms an invaluable tool for a thorough investigation.

This article summarized the latest R&D progress of acetylcholine chloride, the Mechanism of Action for acetylcholine chloride, and the drug target R&D trends for acetylcholine chloride.

FDA accepts Priority Review of Odronextamab BLA for Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma.

This article summarized the latest R&D progress of acetaminophen/butalbital/caffeine, the Mechanism of Action for acetaminophen/butalbital/caffeine, and the drug target R&D trends for acetaminophen/butalbital/caffeine.

TIL therapy uses the patient's own immune cells from the solid tumor microenvironment to kill tumor cells.

This article summarized the latest R&D progress of carglumic acid, the Mechanism of Action for carglumic acid, and the drug target R&D trends for carglumic acid.

IMUNON released preliminary PFS and OS statistics related to IMNN-001 from its Phase 1/2 OVATION 2 Investigation.

This article summarized the latest R&D progress of Regadenoson, the Mechanism of Action for Regadenoson, and the drug target R&D trends for Regadenoson.

Fusion protein technology is a purposeful gene fusion and protein expression method to obtain large amounts of standard fusion proteins.

This article summarized the latest R&D progress of Revefenacin, the Mechanism of Action for Revefenacin, and the drug target R&D trends for Revefenacin.

Structure Therapeutics has revealed encouraging results from its Phase 1b incremental dose study of its exclusive oral GLP-1 receptor agonist, GSBR-1290, in overweight or obese individuals.